Investors & Media

news archive »

Investor Contact:

Joshua Drumm, Ph.D. / Jason Rando
Tiberend Strategic Advisors, Inc.

(212) 827-0020

jdrumm@tiberend.com , jrando@tiberend.com

Press Releases

14-May-2013	Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update
9-May-2013	Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
17-Apr-2013	Victory Park Capital Completes Public Auction of Unigene’s Peptelligence™ Drug Delivery Platform
8-Apr-2013	Unigene Secures Financing to Extend Operating Runway in Conjunction with Strategic Reorganization – Victory Park Capital Commences Process for Potential Sale of PeptelligenceTM Drug Delivery Platform
12-Mar-2013	Unigene Announces Fourth Quarter and Full-Year 2012 Results
6-Mar-2013	Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin
13-Feb-2013	UNIGENE RECEIVES 2013 DRUG DELIVERY PARTNERSHIPS
7-Feb-2013	Unigene to Present at the 17th Annual Drug Delivery Partnerships Meeting
31-Jan-2013	Unigene Completes Financial Statement Amendment
15-Jan-2013	Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin